Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high‐dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS‐86)
暂无分享，去创建一个
S. Leyvraz | S. Bielack | H. Jürgens | N. Graf | R. Kotz | G. Delling | J. Ritter | R. Ladenstein | M. Salzer-Kuntschik | R. Mertens | R. Erttmann | K. Winkler | C. Kusnierz-Glaz | P. Weinel | C. Greenshaw | G. Gädicke | M. Salzer‐Kuntschik | MD K. Winkler | MD S. Bielack | MD G. Delling | MD M. Salzer-Kuntschik | MD R. Kotz | MD C. Greenshaw | Mdii H. Jiirgens | MD J. Ritter | MD Y C. Kusnierz-Glaz | MD R. Erttmann | MD G. Gadicke | MDtt N. Graf | MD S R. Ladenstein | Leyvraz | MD § R. Mertens | MDY‘IT P. Weinel